Taurine reduces the secretion of apolipoprotein B100 and lipids in HepG2 cells

Lipids in Health and Disease

Volumn 7, Issue , 2008, Pages

  Yanagita, Teruyoshi ^a   Han, Seo Young ^a,b   Hu, Ying ^a   Nagao, Koji ^a   Kitajima, Hideaki ^c   Murakami, Shigeru ^c  

^a SAGA UNIVERSITY   (Japan)

^b Jeonnam Natural Resources Research Institute   (South Korea)

^c TAISHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B100; CARBON 14; CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE; CHOLESTEROL ESTER; LIPID; OLEIC ACID; TAURINE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LIPID METABOLISM; LIPOGENESIS; PROTEIN ANALYSIS; PROTEIN SECRETION; BIOSYNTHESIS; DRUG ANTAGONISM; DRUG EFFECT; LIVER CELL CARCINOMA; METABOLISM; SECRETION; TUMOR CELL CULTURE;

APOLIPOPROTEIN B-100; CARCINOMA, HEPATOCELLULAR; CHOLESTEROL; CHOLESTEROL ESTERS; HUMANS; LIPID METABOLISM; LIPIDS; TAURINE; TRIGLYCERIDES; TUMOR CELLS, CULTURED;

EID: 55349118528     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-7-38     Document Type: Article

References (28)

1. Is taurine a functional nutrient? T Bouckenooghe C Remacle B Reusens, Curr Opin Clin Nutr Metab Care 2006 9 728 733 17053427
2. Transport and function of taurine in mammalian cells and tissues. CC Yan R Masella Y Sun A Cantafora, Acta Toxicol Ther 1991 12 277 298
3. Taurine: Its biological role and clinical implications. RW Chensney, Adv Pediatr 1985 32 1 42 3909770
4. The effect of taurine treatment on oxidative stress in experimental liver fibrosis. M Refik Mas B Comert K Oncu SA Vural C Akay I Tasci E Ozkomur M Serdar N Mas G Alcigir N Yener, Hepatol Res 2004 28 207 215 10.1016/j.hepres. 2003.11.012 15040961
5. Therapeutic effect of taurine administration on carbon tetrachloride-induced hepatic injury. T Nakashima T Taniko K Kuriyama, Jpn J Pharmacol 1982 32 583 589 10.1254/jjp.32.583 7131945
6. Taurine: A possible urinary marker of liver damage. A study of taurine excretion on carbon tetrachloride-treated rats. CJ Waterfield JA Turton MDC Scales JA Timbrell, Arch Toxicol 1991 65 548 555 10.1007/BF01973715 1685880
7. Taurine enhances low density lipoprotein binding. ZF Stephan SL Lindsey KC Hayes, J Biol Chem 1987 262 6069 6073 3571247
8. Effect of taurine on cholesterol gallstione in cholesterol-fed mice. K Tsuji Y Yamanaka M Ichikawa, Sufur Amino aci 1983 6 249 255
9. Taurine increases bile acid poll size and reduces bile saturation index in the hamster. S Bellentani M Pecorari P Cordoma P Marchegiano F Manenti E Bosisio E Defabiani G Galli, J Lipid Res 1987 28 9 1021 1027 3655556
10. Effect of taurine levels on liver lipid metabolism: an in vivo study in the rat. CC Yan E Bravo A Cantafora, Proc Soc Exp Biol Med 1993 202 88 96 8424099
11. Taurine prevents ethanol-induced alterations in lipids and ATPases in rat tissues. G Pushpakiran K Mahalakshmi P Viswanathan CV Anuradha, Pharmacol Rep 2005 57 578 587 16227640
12. Dietary taurine content changes liver lipids in cats. A Cantafora I Blotta SS Rossi AF Hofmann JA Sturman, J Nutr 1991 121 10 1522 1528 1765815
13. Effect of taurine administration on serum lipid and biliary lipid composition in man. N Tanno S Oikawa M Koizumi Y Fujii S Hori N Suzuki E Sakuma H Kotake K Namai T Toyota, Tohoku J Exp Med 1989 159 91 99 10.1620/tjem.159.91 2609337
14. Taurine nutrition. KC Hayes, Nutr Res Rev 1988 1 99 113 10.1079/NRR19880009
15. Taurine, a possible urinary marker of liver damage: a study of taurine excretion on carbon tetrachloride-treated rats. CJ Waterfield JA Turtion MDC Scales JA Timbrell, Arch Toxicol 1991 65 548 555 10.1007/BF01973715 1685880
16. Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis. SO Olofsson J Boren, J Intern Med 2005 258 395 410 10.1111/j.1365-2796.2005.01556.x 16238675
17. The effects of low density lipoproreins, cholesterol, and 25-hydroxycholesterol on apolipoprotein B gene expression in HepG2 cells. N Dashti, J Biol Chem 1992 267 7160 7169 1313035
18. Effects of simvastatin, a cholesterol synthesis inhibitor, on phosphatidylcholine synthesis in HepG2 cells. T Yanagita K Yamamoto S Ishida K Sonda F Morito K Saku T Sakai, Clin Ther 1994 16 200 208 8062316
19. Effect of ACAT inhibitors, HL-004 and CI-976, on cholesterol esterification and lipoprotein secretion in HepG2 cells. T Yanagita K Sonda H Yotsumoto K Yamamoto S Murakami, Curr Thera Res 1994 57 787 795
20. Intracellular triacyglycerollipase: its role in the assembly of hepatic very-low-density lipoprotein (VLDL). GF Gibbons D Wiggins, Adv Enzyme Regul 1995 35 179 198 10.1016/0065-2571(94)00006-O 7572343
21. Effect of ethanolon the synthesis and secretion of apoA-I- and apoB containing lipoproteins in HepG2 cells. N Dashti AF Franklin DR Abrahamson, J Lipid Res 1996 37 810 822 8732781
22. Synthesis and secretion of apolipoprotein B from cultured liver cells. HN Ginsberg, Curr Opin Lipidol 1995 6 275 280 10.1097/00041433-199502000-00001 8520849
23. Absence of micresomal triglyceriglyceride ransfer protein in individuals with abetalipopreteinemis. JR Wetterau LP Aggerbeck ME Bouma C Eisenberg A Munck M Hermier J Schmitz G Gay DJ Rader RE Gregg, Science 1992 258 999 1001 10.1126/science.1439810 1439810
24. An improved MTT assay. D Sladowski SJ Steer RH Clothier M Balls, J Immunol Methods 1993 157 203 207 10.1016/0022-1759(93)90088-O 8423364
25. Protein measure with the Folin reagent. OH Lowry NJ Rosebrough AL Farr RJ Randall, J Biol Chem 1951 193 265 275 14907713
26. A rapid method of total lipid extraction and purificication. EG Bligh WJ Dyer, Can J Biochem Physiol 1959 37 911 917 13671378
27. S-Propylcysteine reducesapolipoprotein B100 and triacylglycerol secretion in HepG2 cells. SY Han T Anno T Yanagita, Nutrition 2002 18 505 509 10.1016/S0899-9007(02)00749-9 12044824
28. Two monoclonal antibody-based enzyme-linked assays of apolipoprotein B. SG Young RS Smith DM Hogle LK Curtiss L Witztum, Clin Chem 1986 32 1484 1490 3524903